Bayer today announced that the U.S. Food and Drug Administration (FDA) approved AMBELVIST® (gadoquatrane), a new, intravenous macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) indicated for ...
CMS has permanently authorized virtual contrast supervision beginning January 1, 2026, allowing radiologists to oversee contrast injections via real-time audio and video technology. Professional ...
AWARENESS MONTH. AND ALL THIS MONTH, WPBF 25 NEWS WILL FEATURE WOMEN WHO HAVE UNDERGONE TREATMENT. AND WE’LL ALSO HIGHLIGHT THE LATEST TECHNOLOGY BEING USED TO FIGHT BREAST CANCER AT JUPITER MEDICAL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results